200,000+ products from a single source!
sales@angenechem.com
CAS No: 190277-13-5 Catalog No: AG002EG1 MDL No:
Title | Journal |
---|---|
Involvement of carbonic anhydrases in the ocular hypotensive effect of melatonin analogue 5-MCA-NAT. | Journal of pineal research 20120401 |
Regulation of ocular adrenoceptor genes expression by 5-MCA-NAT: implications for glaucoma treatment. | Pharmacogenetics and genomics 20110901 |
Design of novel melatonin analogs for the reduction of intraocular pressure in normotensive rabbits. | The Journal of pharmacology and experimental therapeutics 20110601 |
Design and synthesis of naphthalenic derivatives as new ligands at the melatonin binding site MT3. | European journal of medicinal chemistry 20110501 |
The use of mucoadhesive polymers to enhance the hypotensive effect of a melatonin analogue, 5-MCA-NAT, in rabbit eyes. | Investigative ophthalmology & visual science 20110318 |
Melatonin inhibits tachykinin NK₂ receptor-triggered 5-HT release from guinea pig isolated colonic mucosa. | British journal of pharmacology 20110301 |
MT2 receptors mediate the inhibitory effects of melatonin on nitric oxide-induced relaxation of porcine isolated coronary arteries. | The Journal of pharmacology and experimental therapeutics 20110101 |
Molecular and cellular pharmacological properties of 5-methoxycarbonylamino-N-acetyltryptamine (MCA-NAT): a nonspecific MT3 ligand. | Journal of pineal research 20100401 |
An unexpected effect of 5-MCA-NAT in chick retinal development. | International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 20091001 |
5-MCA-NAT does not act through NQO2 to reduce intraocular pressure in New-Zealand white rabbit. | Journal of pineal research 20090901 |
Ophthalmic formulations of the intraocular hypotensive melatonin agent 5-MCA-NAT. | Experimental eye research 20090301 |
A novel quantitative structure-activity relationship method to predict the affinities of MT3 melatonin binding site. | European journal of medicinal chemistry 20081201 |
Design and synthesis of benzofuranic derivatives as new ligands at the melatonin-binding site MT3. | Bioorganic & medicinal chemistry 20080501 |
Requirement of intact sympathetic transmission for the ocular hypotensive effects of melatonin and 5-MCA-NAT. | Autonomic neuroscience : basic & clinical 20071230 |
Cellular mechanisms involved in the melatonin inhibition of HT-29 human colon cancer cell proliferation in culture. | Journal of pineal research 20070901 |
Mechanisms of N-methyl-D-aspartate receptor inhibition by melatonin in the rat striatum. | Journal of neuroendocrinology 20041101 |
Effect of 5-MCA-NAT, a putative melatonin MT3 receptor agonist, on intraocular pressure in glaucomatous monkey eyes. | Journal of glaucoma 20041001 |
Melatonin inhibits nitrate tolerance in isolated coronary arteries. | British journal of pharmacology 20030801 |
Ocular hypotensive effects of melatonin receptor agonists in the rabbit: further evidence for an MT3 receptor. | British journal of pharmacology 20030301 |
Melatonin receptors in rat hippocampus: molecular and functional investigations. | Hippocampus 20020101 |
Melatonin and N-acetylserotonin inhibit leukocyte rolling and adhesion to rat microcirculation. | European journal of pharmacology 20011102 |
Expression and functional characterization of the mt1 melatonin receptor from rat brain in Xenopus oocytes: evidence for coupling to the phosphoinositol pathway. | Journal of pineal research 20010401 |
Involvement of melatonin MT(3) receptors in the regulation of intraocular pressure in rabbits. | European journal of pharmacology 20010330 |
© 2019 Angene International Limited. All rights Reserved.